COMPOSITION PHARMACEUTIQUE POUR TRAITEMENT DE CARDIOPATHIE RÉFRACTAIRE

• 收藏
• 分享

专利权人:

Cardio Incorporated;Osaka University

发明人:

申请号：

EP17885962.5

公开号：

EP3569249A1

申请日:

2017.12.27

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention provides a pharmaceutical composition for use in treating an intractable heart tissue fibrosis disease accompanied by chronic heart failure. The pharmaceutical composition for use in treating an intractable heart tissue fibrosis disease accompanied by chronic heart failure comprises, as an active ingredient, at least one member selected from the group consisting of protease inhibitors, thromboxane A2 synthase inhibitors, thromboxane A2 synthase antagonists, phosphodiesterase (PDE) inhibitors, tyrosine kinase inhibitors, HMG-CoA reductase inhibitors, and antifibrotic agents. (The pharmaceutical composition includes biodegradable polymer-encapsulated, long-acting preparations thereof.)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/